PeakMax Capsules recall
PeakMax Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: PeakMax, San Francisco, CA, www.PeakMax.com
Why was PeakMax Capsules recalled?
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: 230811, Exp: 08/11/2025
- Product
- PeakMax Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: PeakMax, San Francisco, CA, www.PeakMax.com
- Recalling firm
- Boulla LLC
- Quantity
- Unknown
- Distribution
- Nationwide within the United States
- Recall date
- December 11, 2024
- Classification
- Class I
- Status
- Ongoing
- Agency
- FDA (drug)